Rapid and long-lasting decrease of T-regulatory cells in patients with myelofibrosis treated with ruxolitinib

被引:0
|
作者
M Massa
V Rosti
R Campanelli
G Fois
G Barosi
机构
[1] Biotechnology Research Area,
[2] IRCCS Policliico S. Matteo Foundation,undefined
[3] Center for the Study of Myelofibrosis,undefined
[4] Biotechnology Research Area,undefined
[5] IRCCS Policlinico S. Matteo Foundation,undefined
来源
Leukemia | 2014年 / 28卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:449 / 451
页数:2
相关论文
共 50 条
  • [41] Revised assessment of response and long-term discontinuation rates among 111 patients with myelofibrosis treated with momelotinib or ruxolitinib
    R A Abdelrahman
    K H Begna
    A Al-Kali
    W J Hogan
    M R Litzow
    A Tefferi
    Leukemia, 2015, 29 : 498 - 500
  • [42] Long-lasting CD8 T cell memory in the absence of CD4 T cells or B cells
    DiRosa, F
    Matzinger, P
    JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (05): : 2153 - 2163
  • [43] T-Effective, T-Regulatory and B-Cells in Newly Natalizumab-Treated MS Patients: Implications for Recognition of Early Response to Therapy
    Alexoudi, Athanasia
    Marousi, Stella
    Gogali, Foteini
    Kalamatas, Themistokles
    Paterakis, Georgios
    Panagopoulos, Grigorios
    Karageorgiou, Climentine E.
    NEUROLOGY, 2011, 76 (09) : A241 - A241
  • [44] Decreased levels of immune-regulatory cytokines in patients with immune thrombocytopenia and long-lasting overexpression of these cytokines in the splenectomized patients
    Wang, Xiaofeng
    Li, Feng
    Li, Yang
    Sun, Lihua
    Meng, Yahong
    Fan, Xiaohong
    Wang, Xuelian
    Wu, Duojiao
    Cheng, Yunfeng
    Hua, Fanli
    JOURNAL OF LEUKOCYTE BIOLOGY, 2021, 110 (02) : 335 - 341
  • [45] NORMAL LYMPHOCYTE-T FUNCTION IN PATIENTS WITH HODGKINS-DISEASE IN LONG-LASTING REMISSION
    LAURIA, F
    RASPADORI, D
    FOA, R
    TAZZARI, PL
    LUSSO, P
    FIERRO, MT
    MATERA, L
    BACCARANI, M
    TURA, S
    TUMORI, 1986, 72 (01) : 75 - 80
  • [46] TOLEROGENIC INTESTINAL TRANSPLANT PROTOCOL IMPROVES LONG-TERM SURVIVAL BY PROMOTION OF T-REGULATORY CELLS
    Ceulemans, Laurens
    Braza, Faouzi
    Monbaliu, Diethard
    Jochmans, Ina
    De Hertogh, Gert
    Du Plessis, Johannie
    Marie-Paule, Emonds
    Koshiba, Takaaki
    Sprangers, Ben
    Waer, Mark
    Brouard, Sophie
    Pirenne, Jacques
    TRANSPLANT INTERNATIONAL, 2015, 28 : 585 - 585
  • [47] Dendritic cells loaded with stressed tumor cells elicit long-lasting protective tumor immunity in mice depleted of CD4+CD25+ regulatory T cells
    Prasad, SJ
    Farrand, KJ
    Matthews, SA
    Chang, JH
    McHugh, RS
    Ronchese, F
    JOURNAL OF IMMUNOLOGY, 2005, 174 (01): : 90 - 98
  • [48] Functional activity of T-regulatory cells in healthy donors and patients with rheumatoid arthritis, in vitro assay
    Shevyrev, D.
    Sizikov, A.
    Pashkina, E.
    Grishina, L.
    Kozlov, V.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 940 - 941
  • [49] Patients with Wegener's granulomatosis demonstrate a relative deficiency and functional impairment of T-regulatory cells
    Morgan, Matthew D.
    Day, Clara J.
    Piper, Karen P.
    Khan, Naeem
    Harper, Lorraine
    Moss, Paul A.
    Savage, Caroline O. S.
    IMMUNOLOGY, 2010, 130 (01) : 64 - 73
  • [50] T-regulatory cells in patients with squamous cell cancers migrate increasingly under chemokine influence
    Funkhauser, P.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2007, 183 : 88 - 89